Self-renewal mechanism of cancer stem cells

Abstract

WANG Tong, QI Xiao-Fei, ZHANG Ri. Self-renewal mechanism of cancer stem cells[J]. Journal of International Oncology, 2014, 41(12): 896-898.

［1］ Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells［J］. Cancer Res, 2006, 66(19): 93399344. ［2］ Prezioso C, Orlando V. Polycomb proteins in mammalian cell differentiation and plasticity［J］. FEBS Lett, 2011, 585(13): 20672077. ［3］ Su Y, Deng B, Xi R. Polycomb group genes in stem cell selfrenewal: a doubleedged sword［J］. Epigenetics, 2011, 6(1): 1619. ［4］ Kaustov L, Ouyang H, Amaya M, et al. Recognition and specificity determinants of the human cbx chromodomains［J］. J Biol Chem, 2011, 286(1): 521529. ［5］ Kalushkova A, Frykns M, Lemaire M, et al. Polycomb target genes are silenced in multiple myeloma［J］. PLoS One, 2010, 5(7): e11483. ［6］ Vincent A, Van Seuningen I. On the epigenetic origin of cancer stem cells［J］. Biochim Biophys Acta, 2012, 1826(1): 8388. ［7］ Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences［J］. Stem Cells, 2012, 30(3): 372378. ［8］ Schuringa JJ, Vellenga E. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells［J］. Curr Opin Hematol, 2010, 17(4): 294299. ［9］ Rizo A, Olthof S, Han L, et al. Repression of BMI1 in normal and leukemic human CD34+ cells impairs selfrenewal and induces apoptosis［J］. Blood, 2009, 114(8): 14981505. ［10］ Xu Z, Liu H, Lv X, et al. Knockdown of the Bmi1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF7［J］. Oncol Rep, 2011, 25(2): 409418. ［11］ Kreso A, van Galen P, Pedley NM, et al. Selfrenewal as a therapeutic target in human colorectal cancer［J］. Nat Med, 2014, 20(1): 2936. ［12］ Yu CC, Lo WL, Chen YW, et al. Bmi1 regulates snail expression and promotes metastasis ability in head and neck squamous cancerderived ALDH1 positive cells［J］. J Oncol, 2011. ［13］ Honig A, Weidler C, Husler S, et al. Overexpression of polycomb protein BMI1 in human specimens of breast, ovarian, endometrial and cervical cancer［J］. Anticancer Res, 2010, 30(5): 15591564. ［14］ Luo M, Shen DX, Guo XT, et al. Clinicopathological and prognostic significance of Bmi1 expression in human cervical cancer［J］. Acta Obstet Gynecol Scand, 2011, 90(7): 737745. ［15］ Tu Y, Gao X, Li G, et al. MicroRNA218 inhibits glioma invasion, migration, proliferation, and cancer stemlike cell selfrenewal by targeting the polycomb group gene Bmi1［J］. Cancer Res, 2013, 73(19): 60466055. ［16］ van Vlerken LE, Kiefer CM, Morehouse C, et al. EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter［J］. Stem Cells Transl Med, 2013, 2(1): 4352. ［17］ Chatoo W, Abdouh M, Duparc RH, et al. Bmi1 distinguishes immature retinal progenitor/stem cells from the main progenitor cell population and is required for normal retinal development［J］. Stem Cells, 2010, 28(8): 14121423. ［18］ Yadirgi G, Leinster V, Acquati S, et al. Conditional activation of Bmi1 expression regulates selfrenewal, apoptosis, and differentiation of neural stem/progenitor cells in vitro and in vivo［J］. Stem Cells, 2011, 29(4): 700712. ［19］ Pritsker M, Ford NR, Jenq HT, et al. Genomewide gainoffunction genetic screen identifies functionally active genes in mouse embryonic stem cells［J］. Proc Natl Acad Sci, 2006, 103(18): 69466951. ［20］ Lin SL, Chang DC, Ying SY, et al. MicroRNA miR302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways［J］. Cancer Res, 2010, 70(22): 94739482. ［21］ Mathieu J, RuoholaBaker H. Regulation of stem cell populations by microRNAs［J］. Adv Exp Med Biol, 2013, 786: 329351. ［22］ Yu F, Yao H, Zhu P, et al. Let7 regulates self renewal and tumorigenicity of breast cancer cells［J］. Cell, 2007, 131(6): 11091123. ［23］ Guo L, Chen C, Shi M, et al. Stat3coordinated Lin28let7HMGA2 and miR200ZEB1 circuits initiate and maintain oncostatin Mdriven epithelialmesenchymal transition［J］. Oncogene, 2013, 32(45): 52775282. ［24］ Won HY, Lee JY, Shin DH, et al. Loss of Mel18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway［J］. FASEB J, 2012, 26(12): 50025013. ［25］ Harrison H, Farnie G, Howell SJ, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor［J］. Cancer Res, 2010, 70(2): 709718. ［26］ Po A, Ferretti E, Miele E, et al. Hedgehog controls neural stem cells through p53independent regulation of Nanog［J］. EMBO J, 2010, 29(15): 26462658.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Self-renewal mechanism of cancer stem cells

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments